Recent news on Timolol

ISTA reports 91% increase in first quarter revenue  -  Apr 26, 2007
OSN SuperSite (subscription),Revenue from sales of Istalol (timolol maleate 0.5%) increased 29% to total $2.2 million, while revenue from Vitrase (hyaluronidase) sales increased 25% to

Alcon's First Quarter Sales Rise 14.3 Percent  -  Apr 25, 2007
American Digital Networks (press release),Pediatric patent extensions were granted to Alcon for Betoptic S(R) ophthalmic suspension and to Falcon Pharmaceuticals for Timolol GFS, which extends the

Alcon's First Quarter Sales Rise 14.3 Percent  -  26 Apr 2007
American Digital Networks (press release),Pediatric patent extensions were granted to Alcon for Betoptic S(R) ophthalmic suspension and to Falcon Pharmaceuticals for Timolol GFS, which extends the

Alcon's First Quarter Sales Rise 14.3 Percent  -  26 Apr 2007
Genetic Engineering News (press release),Pediatric patent extensions were granted to Alcon for Betoptic S(R) ophthalmic suspension and to Falcon Pharmaceuticals for Timolol GFS, which extends the

Heart Failure and Its Management With beta-Blockade: Potential ...  -  Mar 31, 2007
HeartZine,Carvedilol, propranolol, and timolol are recommended for post-myocardial infarction LV dysfunction. Unfortunately, these evidence-based therapies are often

Alcon global sales up 16.1% in fourth quarter 2006  -  Feb 12, 2007
OSN SuperSite (subscription),Azopt (brinzolamide) and DuoTrav (travoprost 0.004%, timolol 0.5%), as well as the US launch of Travatan Z (benzalkonium chloride-free travoprost).

Some facts about migraines  -  Feb 7, 2007
Pittsburgh Post Gazette,These include propranolol (Inderal), timolol (Blocadren), topiramate (Topamax) and divalproex sodium (Depakote). These have had many years of use and make

Allergan Reports Fourth Quarter Operating Results  -  Jan 31, 2007
Genetic Engineering News (press release),On December 21, 2006, Allergan announced that the FDA issued an approvable letter for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic

Allergan Announces FDA Issues Approvable Letter for Combigan ...  -  Dec 22, 2006
PharmaLive.com (press release),COMBIGAN(TM) includes two agents known to reduce IOP - ALPHAGAN(R) (brimonidine tartrate ophthalmic solution 0.2%) and timolol ophthalmic solution 0.5%,

Allergan: FDA Seek More Data on Combigan  -  Dec 22, 2006
Houston Chronicle,Combigan is a combination of Alphagan, already FDA approved for glaucoma, and timolol ophthalmic solution 0.5 percent, a blood pressure medication.

Allergan Announces FDA Issues Approvable Letter for Combigan ...  -  Dec 22, 2006
PharmaLive.com (press release),COMBIGAN(TM) includes two agents known to reduce IOP - ALPHAGAN(R) (brimonidine tartrate ophthalmic solution 0.2%) and timolol ophthalmic solution 0.5%,

Allergan: FDA Seek More Data on Combigan  -  Dec 22, 2006
Houston Chronicle,Combigan is a combination of Alphagan, already FDA approved for glaucoma, and timolol ophthalmic solution 0.5 percent, a blood pressure medication.

Foro de Shell Security - Seguridad informática  Oct 26, 2006
...translocations (ie, the genetic hallmark of lymphoid tikosyn alignancies), or tumor suppressor loci can be inactivated by chr timolol mosomal deletion or ... -Shell Security, Prevention Strategies Reviewed for Women With Migraines  Sep 6, 2006
These include beta-blockers (propranolol, timolol, atenolol, metoprolol, nadolol); tricyclic antidepressants (amitriptyline, nortriptyline, protriptyline ... -Medscape (subscription)

Centron Experiences Unprecedented Growth: Its First Anniversary  Aug 24, 2006
Additionally, Centron was named medical communications agency of record for Combigan? (brimonidine tartrate/timolol maleate), a new product from Allergan. -PharmaLive.com

Allergan Reports Second Quarter Operating Results; Total Product ...  Aug 2, 2006
GANFORT(R) is Allergan's LUMIGAN(R)/timolol combination product (bimatoprost/timolol ophthalmic solution) for the treatment of glaucoma, and is indicated for ... -Business Wire

International Approvals: Takepron, Ganfort, Kaletra  Jul 5, 2006
...mg capsules and tablets), allowing its use in the treatment of nonerosive reflux esophagitis; the European Commission has approved bimatoprost/timolol 0.03%0.5 ... -Medscape (subscription)

Yale Biomedical Engineers Receive Prestigious Early Career Awards  Jul 17, 2006
Erin Lavik was granted the award for her project "Sustained delivery of timolol maleate for management of elevated IOP for glaucoma," in collaboration with ... -Medical News Today

Q&A: Beta-blockers  Jun 28, 2006
Beta-blockers go under different names, including: Acebutolol, Atenolol, Bisoprolol, Metoprolol, Oxprenolol, Pindolol, Propanaolol, Sotalol, and Timolol. ... -BBC News

Allergan Announces FDA Approval of LUMIGAN(R) As First-Line ...  Jun 23, 2006
EJ, Schuman JS, Goldberg I, et al., for the Bimatoprost Study Groups 1 and 2. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ... -International News Service

Allergan Gets FDA Nod For Eye Drop LUMIGAN As First-line Treatment ...  Jun 23, 2006
The company said that GANFORT offers powerful IOP-lowering efficacy compared to the free combination of bimatoprost and timolol maleate and greater efficacy ... -Trading Markets



Study Demonstrates Benefits of Combination Treatment for Glaucoma  May 11, 2006
...achieved clinically significant additional reduction in intraocular pressure (IOP) when treated with Cosopt® (dorzolamide hydrochloride/timolol maleate) alone ... - DG News

NEW STUDY DEMONSTRATES A SINGLE COMPOUND AS EFFECTIVE AS A FIXED ...  May 3, 2006
...bimatoprost) is as effective alone at lowering intraocular pressure (IOP) as a fixed combination (XALACOM) of latanoprost (Xalatan) combined with timolol. ... - ITNews

Allergan Reports First Quarter Operating Results; Pharmaceutical ...  May 3, 2006
...for Medicinal Products for Human Use (CHMP) recommended that the European Commission approve GANFORT(R), Allergan's LUMIGAN(R)/timolol combination product ... - Genetic Engineering News

Allergan Posts Q1 Loss, Forecasts Q2 Results Below Wall Street ...  May 3, 2006
...the Committee for Medicinal Products for Human Use recommended that the European Commission approve GANFORT, Allergan's LUMIGAN/timolol combination product for ... - Trading Markets

(BW) Alcon's First Quarter Sales Rise 8.1 Percent, Net Earnings ...  Apr 24, 2006
DuoTrav(TM), a fixed combination of travoprost 0.004% and timolol 0.5%, received a positive recommendation for approval in the European Union by the ... - Houston Chronicle

Alcon Q1 Net Earnings Rise 18.5% Primarily On Healthy Sales Growth ...  Apr 24, 2006
DuoTrav, a fixed combination of travoprost 0.004% and timolol 0.5%, received a positive recommendation for approval in the European Union by the Committee for ... - Trading Markets

Glaucoma treatment has options  Apr 23, 2006
For example, beta blockers such as levobunolol (Betagan) or timolol (Betimol, Timoptic) can reduce the production of aqueous humor, and prostaglandin analogues ... - Fort Wayne Journal Gazette





Allergan Receives Positive Opinion for GANFORT(R) (LUMIGAN(R) ...  Mar 24, 2006
...for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve GANFORT(R), Allergan's LUMIGAN(R)/timolol combination product ... - Genetic Engineering News

Allergan Receives Positive Opinion for GANFORT(R) (LUMIGAN(R) ...  Mar 24, 2006
...for Medicinal Products for Human Use (CHMP) has recommendedthat the European Commission approve GANFORT(R), Allergan'sLUMIGAN(R)/timolol combination product ... - Finanzen.net

Allergan Receives Positive Opinion for Ganfort (Lumigan/Timolol ...  Mar 24, 2006
...for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve Ganfort®, Allergan's Lumigan®/timolol combination product ... - DG News

Committee for Medicinal Products for Human Use Summary of Positive ...  Mar 24, 2006
The active substances of Ganfort are bimatoprost and timolol (as timolol maleate), an antiglaucoma agent (ATC code: SO1ED 51), which contains a combination of ... - PharmaLive.com

Allergan's eye drug recommended in Europe  Mar 27, 2006
The product combines the Allergan's eye drops Lumigan that reduces the pressure in the eye with timolol, used to treat high blood pressure. ... - Pharmaceutical Business Review

European Medicines Agency: Committee for Medicinal Products for ...  Mar 24, 2006
§ Ganfort (bimatoprost/timolol), Allergan Pharmaceuticals Ireland. Ganfort is an eye-drop solution, intended for reduction of intraocular ... - PharmaLive.com



Santen Announces Preliminary Results of Overseas Clinical Trials ...  Feb 14, 2006
...for DE-085 in the US and Europe after completing a comprehensive statistical analysis of data from another comparison study versus timolol maleate ophthalmic ... - Genetic Engineering News,

CMPH - Initial Marketing Authorisation Applications,Europe ...  Feb 24, 2006
...-- Duotrav (travoprost/timolol maleate), Alcon Laboratories. Duotrav is an eye-drops solution, intended for the decrease of intraocular ... - Medical News Today,

Merck Announces Strong Full-Year and Fourth-Quarter 2005 Earnings ...  Jan 31, 2006
Merck has elected not to enforce two USpatents listed with the FDA which cover the combination of dorzolamideand timolol, the two active ingredients in COSOPT. ... - Finanzen.net

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional